C3d binding to the circumsporozoite protein carboxy-terminus deviates immunity against malaria

International Immunology

Volumn 17, Issue 3, 2005, Pages 245-255

  Bergmann Leitner, Elke S ^a   Scheiblhofer, Sandra ^b   Weiss, Richard ^b   Duncan, Elizabeth H ^a   Leitner, Wolfgang W ^c   Chen, Defeng ^a   Angov, Evelina ^a   Khan, Farhat ^a   Williams, Jackie L ^a   Winter, David B ^a   Thalhamer, Josef ^b   Lyon, Jeffrey A ^a   Tsokos, George C ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b UNIVERSITY OF SALZBURG   (Austria)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Complement; Host defense; Malaria; T lymphocytes

Indexed keywords

CIRCUMSPOROZOITE PROTEIN; COMPLEMENT COMPONENT C3D; DNA VACCINE; EPITOPE; INTERLEUKIN 4; PROTEIN ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA FLANKING REGION; DRUG EFFICACY; FEMALE; GENE GUN; GENE VECTOR; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MALARIA; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMODIUM BERGHEI; PRIORITY JOURNAL; PROTECTION; PROTEIN BINDING; SPLEEN CELL;

ANIMALS; ANTIBODIES, PROTOZOAN; BASE SEQUENCE; COMPLEMENT C3D; MALARIA; MICE; MOLECULAR SEQUENCE DATA; PLASMODIUM BERGHEI; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; SPLEEN; TH2 CELLS;

EID: 20144379526     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh205     Document Type: Article

References (42)

1. Leitner, W. W., Seguin, M. C., Ballou, W. R. et al. 1997. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. J. Immunol. 159:6112.
2. Weiss, R., Leitner, W. W., Scheiblhofer, S. et al. 2000. Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein. Infect. Immun. 68:5914.
3. Scheiblhofer, S., Chen, D., Weiss, R. et al. 2001. Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improves protection against malaria infection. Eur. J. Immunol. 31:692.
4. Tsokos, G. C., Lambris, J. D., Finkelman, F. D., Anastassiou, E. D. and June, C. H. 1990. Monovalent ligands of complement receptor 2 inhibit whereas polyvalent ligands enhance anti-Ig-induced human B cell intracytoplasmic free calcium concentration. J. Immunol. 144:1640.
5. Goeckeritz, B. E., Lees, A., Vos, O., Tsokos, G. C., Kuhlbusch, K. and Mond, J. J. 2000. Enhanced and sustained activation of human B cells by anti-immunoglobulin conjugated to the EBV glycoprotein gp350. Eur. J. Immunol. 30:969.
6. Thornton, B. P., Vetvicka, V. and Ross, G. D. 1996. Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells. Clin. Exp. Immunol. 104:531.
7. Kozono, Y., Abe, R., Kozono, H., Kelly, R. G., Azuma, T and Holers, V. M. 1998. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells. J. Immunol. 160:1565.
8. Fischer, M. B., Ma, M., Goerg, S. et al. 1996. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157:549.
9. Ahearn, J. M., Fischer, M. B., Croix, D. et al. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4:251.
10. Molina, H., Holers, V. M., Li, B. et al. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl Acad. Sci. USA 93:3357.
11. Haas, K. M., Toapanta, F. R., Oliver, J. A. et al. 2004. C3d functions as a molecular adjuvant in the absence of CD21/35 expression, J. Immunol. 172:5833.
12. Dempsey, P. W., Allison, M. E., Akkaraju, S., Goodnow, C. C. and Fearon, D. T. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271:348.
13. Ross, T. M., Xu, Y., Bright, R. A. and Robinson, H. L. 2000. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat. Immunol. 1:127.
14. Ross, T. M., Xu, Y., Green, T. D., Montefiori, D. C. and Robinson, H. L. 2001. Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins. AIDS Res. Hum. Retroviruses 17:829.
15. Green, T. D., Newton, B. R., Rota, P. A., Xu, Y., Robinson, H. L. and Ross, T. M. 2002. C3d enhancement of neutralizing antibodies to measles hemagglutinin. Vaccine 20:242.
16. Mitchell, J. A., Green, T. D., Bright, R. A. and Ross, T. M. 2003. Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins. Vaccine 21:902.
17. Pullen, G. R., Fitzgerald, M. G. and Hosking, C. S. 1986. Antibody avidity determination by ELISA using thiocyanate elution. J. Immunol. Methods 86:83.
18. Migliorini, P., Betschart, B. and Corradin, G. 1993. Malaria vaccine: immunization of mice with a synthetic T cell helper epitope alone leads to protective immunity. Eur. J. Immunol. 23:582.
19. Leitner, W. W., Ying, H. and Restifo, N. P. 2000. DNA and RNA-based vaccines: principles, progress and prospects. Vaccine 18:765.
20. Romero, P. J., Tam, J. P., Scnesinger, D. et al. 1988. Multiple T helper epitopes of the circumsporozoite protein of Plasmodium, berghei. Eur. J. Immunol. 18:1951.
21. Romero, P., Corradin, G., Luescher, I. F. and Maryanski, J. L. 1991. H-2Kd-restricted antigenic peptides share a simple binding motif. J. Exp. Med. 174:603.
22. Fischer, R. A. 1932. Statistical Methods for the Research Worker, 4th edn. Oliver & Boyd, Edinburgh, Scotland.
23. Watanabe, I., Ross, T M., Tamura, S. et al. 2003. Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin. Vaccine 21:4532.
24. Green, T. D., Montefiori, D. C. and Ross, T. M. 2003. Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d. J. Virol. 77:2046.
25. + T-cell responses against malaria liver stages. Nat. Med. 8:166.
26. Bergmann, E. S., Ballou, W. R. and Krzych, U. 1997. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites. Cell. Immunol. 180:143.
27. Weiss, R., Scheiblhofer, S., Freund, J., Ferreira, F, Livey, I. and Thalhamer, J. 2002. Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th 1-inducing effect of immunostimulatory CpG motifs in DNA vaccines. Vaccine 20:3148.
28. Kinoshita, T. 1991. Biology of complement: the overture. Immunol. Today 12:291.
29. Passwell, J., Schreiner, G. F, Nonaka, M., Beuscher, H. U. and Colten, H. R. 1988. Local extrahepatic expression of complement genes C3, factor B, C2 and C4 is increased in murine lupus nephritis. J. Clin. Invest 82:1676.
30. Pratt, J. R., Basheer, S. A. and Sacks, S. H. 2003. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat. Med. 8:582.
31. Kaya, Z., Afanasyeva, M., Wang, Y. et al. 2001. Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat. Immunol. 2:739.
32. Roggero, M. A., Meraldi, V., Lopez, J. A. et al. 2000. The synthetic, oxidized C-terminal fragment of the Plasmodium berghei circumsporozoite protein elicits a high protective response. Eur. J. Immunol. 30:2679.
33. Meraldi, V, Audran, R., Romero, J. F. et al. 2003. OM-174, a new adjuvant with a potential for human use, induces a protective response when administered with the synthetic C-terminal fragment 242-310 from the circumsporozoite protein of Plasmodium berghei. Vaccine 21:2485.
34. Schofield, L. and Uadia, P. 1990. Lack of Ir gene control in the immune response to malaria. J. Immunol. 144:2781.
35. Ramasamy, R. 1998. Molecular basis for evasion of host immunity and pathogenesis in malaria. Biochim. Biophys. Acta 1406:10.
36. Goundis, D. and Reid, K. B. M. 1988. Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs. Nature 335:82.
37. 4)β1-Cer] and cholesterol-3-sulfate and its dependence on disulfide bond formation between cysteines in region II. Mol. Biochem. Parasitol. 54:1.
38. Kawamoto, Y., Winger, L. A., Hong, K. et al. 1992. Plasmodium berghei: sporozoites are sensitive to human serum but not susceptible host serum. Exp. Parasitol. 75:361.
39. Egan, J. E., Weber, J. L., Ballou, W. R. et al. 1987. Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development. Science 236:453.
40. Chatterjee, S., Druilhe, P. and Wery, M. 1999. Irradiated sporozoites prime mice to produce high antibody titres upon viable Plasmodium berghei sporozoite challenge, which act upon liver-stage development. Parasitology 118:219.
41. Rogers, W. O., Malik, A., Mellouk, S. et al. 1992. Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc. Natl Acad. Sci. USA 89:9176.
42. Suradhat, S., Braun, R. P., Lewis, J. et al. 2001. Fusion of C3d molecule with bovine rotavirus VP7 or bovine herpesvirus type 1 glycoprotein D inhibits immune responses following DNA immunization. Vet. Immunol. Immunopathol. 83:79.